CLESROVIMAB
UNII VJO29R4CP9

Substance Identification & Data

This profile provides standardized clinical and technical data for Clesrovimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VJO29R4CP9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2429913-18-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

VJO29R4CP9

CAS Registry Number

2429913-18-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CLESROVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

VJO29R4CP9

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C186415

National Cancer Institute reference terminology for clinical and research data.

INN ID

11857

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-210

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Clesrovimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CLESROVIMAB

CLESROVIMAB-CFOR

Common Names & Synonyms

CLESROVIMAB [INN]

CLESROVIMAB [USAN]

CLESROVIMAB [WHO-DD]

CLESROVIMAB CFOR [WHO-DD]

HUMAN IGG1 KAPPA ANTI-RSV F MONOCLONAL ANTIBODY MK-1654

IMMUNOGLOBULIN G1 (262-TYROSINE,264-THREONINE,266-GLUTAMIC ACID), ANTI-(HUMAN RESPIRATORY SYNCYTIAL VIRUS F PROTEIN) (HUMAN MONOCLONAL RB1 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL RB1 .KAPPA.-CHAIN, DIMER